Morepen Laboratories produces 1st test batch of Sputnik V: RDIF

Indian drug manufacturer Morepen Laboratories has produced the first test batch of Sputnik V COVID-19 vaccine, the Russian Direct Investment Fund (RDIF) has said. The first test batch made by the Morepen in Himachal Pradesh will be shipped for quality controls to Gamaleya Institute, it added. Panacea Biotec had also recently received manufacturing license to produce Sputnik V.